Biovica International Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Anders Rylander
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 14yrs |
| CEO ownership | 9.8% |
| Management average tenure | 2yrs |
| Board average tenure | 9yrs |
Recent management updates
Recent updates
CEO
Anders Rylander (54 yo)
14yrs
Tenure
Mr. Anders Rylander serves as Chief Executive Officer of Biovica International AB (publ) since 2010 and serves as its President. Mr. Rylander is the Founder of Arinvest and Co-Founder of Axholmen. He has b...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 14yrs | no data | 9.8% € 1.6m | |
| Chief Financial Officer | 2yrs | no data | 0.075% € 12.4k | |
| Chief Operating Officer | 2yrs | no data | 0.016% € 2.7k | |
| Vice President of Commercial & Marketing | no data | no data | 0.060% € 9.9k | |
| Senior Vice President of Business Development | 5yrs | no data | 0.026% € 4.2k | |
| Head of US Laboratory Operations | 2yrs | no data | no data |
2.0yrs
Average Tenure
56.5yo
Average Age
Experienced Management: 9II's management team is considered experienced (2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 15yrs | no data | 9.8% € 1.6m | |
| Independent Chairman of the Board | 5.8yrs | SEK 481.00k | 1.07% € 176.7k | |
| Independent Director | 4yrs | SEK 200.00k | 0.046% € 7.6k | |
| Independent Director | 9yrs | SEK 263.00k | 0.064% € 10.5k | |
| Independent Director | 11yrs | SEK 219.00k | no data | |
| Independent Director | 12yrs | SEK 250.00k | 0.22% € 35.7k | |
| Independent Director | 5yrs | SEK 100.00k | no data |
9.0yrs
Average Tenure
61yo
Average Age
Experienced Board: 9II's board of directors are considered experienced (9 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/10 01:51 |
| End of Day Share Price | 2025/01/10 00:00 |
| Earnings | 2024/10/31 |
| Annual Earnings | 2024/04/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Biovica International AB (publ) is covered by 3 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jakob Lembke | ABG Sundal Collier Sponsored |
| Dan Akschuti | Pareto Securities |
| Johan Unnerus | Redeye |